CALLAWAY SKINNER: Open Payments
NPI 1245635929 · STATESBORO, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$308 in 11 payments from 7 companies in 2025. Trend: 2023 $77 · 2024 $113 · 2025 $308
Food & beverage: $308
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 3 | $77 |
| SPIRAIR, INC. | 1 | $65 |
| GlaxoSmithKline, LLC. | 3 | $49 |
| Phathom Pharmaceuticals, Inc. | 1 | $41 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $28 |
| GENZYME CORPORATION | 1 | $25 |
| Optinose US, Inc. | 1 | $23 |
Products named: DUPIXENT, SEPTALIGN, NUCALA, VOQUEZNA, NEFFY, Xhance.
Industry payments across GA — which companies pay providers there.
